Marathon Petroleum Corp (0JYA)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 438.58 |
|---|---|
| 52-week range | 161.12 – 498.00 |
| Return, 1 month / 3 months | +12.9% / +41.6% |
| Return, 1 year / 3 years | +127.5% / +218.4% |
| Trend | Uptrend |
| RSI (14) | 48 |
| Volatility (1 year) | 36.8% |
| Worst drawdown (1 year) | -18.6% |
| Average daily value traded | 1.25M USD |
| Dividend yield | 0.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Marathon Petroleum is an American petroleum refining, marketing and transportation company based in Findlay, Ohio. It runs refineries that turn crude oil into fuels such as gasoline and diesel, and it distributes and markets those fuels through wholesale channels and retail service stations, mainly in the United States. Its customers include drivers, businesses and other fuel distributors, and it also operates pipelines and terminals that move crude oil and refined products.
The shares are listed on the London Stock Exchange in UK under the code 0JYA, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Marathon Petroleum Corp (0JYA) trades on the London Stock Exchange in UK. It last closed at USD 438.58 on 27 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 259 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 127.5% and over the last three months it rose 41.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 53.2% | ||
| From 52-week high | -8.6% | ||
| Momentum | 97 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 41.6% | ||
| 6-month return | 92.6% | ||
| 12-month return, skipping the last month | 101.5% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 36.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.6% | ||
| Liquidity | 55 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.25M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.9% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −7.7% |
|---|---|
| 1 month | +12.9% |
| 3 months | +41.6% |
| 6 months | +92.6% |
| 1 year | +127.5% |
| 3 years | +218.4% |
| 5 years | +636.0% |
Signals
| 50-day / 200-day average | 414.58 / 286.19 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 23.98 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 Aug 2026 | USD 1.0000 |
| 19 May 2026 | USD 1.0000 |
| 17 Feb 2026 | USD 1.0000 |
| 18 Nov 2025 | USD 1.0000 |
| 19 Aug 2025 | USD 0.9100 |
| 20 May 2025 | USD 0.9100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.